Form 8-K - Current report:
SEC Accession No. 0000950170-25-047678
Filing Date
2025-03-31
Accepted
2025-03-31 16:00:22
Documents
13
Period of Report
2025-03-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cue-20250331.htm   iXBRL 8-K 63079
2 EX-99.1 cue-ex99_1.htm EX-99.1 175033
3 GRAPHIC img239719762_0.jpg GRAPHIC 11086
  Complete submission text file 0000950170-25-047678.txt   402024

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cue-20250331.xsd EX-101.SCH 44884
15 EXTRACTED XBRL INSTANCE DOCUMENT cue-20250331_htm.xml XML 4511
Mailing Address 40 GUEST STREET BOSTON MA 02135
Business Address 40 GUEST STREET BOSTON MA 02135 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

EIN.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38327 | Film No.: 25792979
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)